March 19, 2009
For Immediate Release
Drug-Eluting Balloons as Alternative to Combined Angioplasty/Stenting, Coverage in 2009 MedMarket Diligence ReportFOOTHILL RANCH, CA ---
As the huge worldwide market for coronary stents -- whether drug-coated, bare metal, bioabsorbable or other -- continues to expand and draw an increasing number of competitors, a handful of innovators are pursuing an alternative idea: drug-eluting balloons. The concept behind the technology is based on the assumption that delivering a rapid release of drugs into the arterial tissue is more effective than the gradual release of drugs, as seen with drug-eluting stents.The "advanced medical technologies" blog has a recent review of drug-eluting balloons, drawn from the forthcoming (March/April) publication of the MedMarket Diligence Report #C245, "Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017."
| Recent Reports from MedMarket Diligence Worldwide Coronary Stents, 2008-2017 (March/April 2009) Worldwide Surgical Sealants, Glues, Wound Closure, 2009-2013 |
The MedMarket Diligence report #C245, "Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017," details the worldwide market for the use of coronary stents in the treatment of coronary artery disease. The report assesses the treatment of coronary artery disease by alternative treatment methodologies (percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other medical/surgical treatment options), with estimated current/forecast caseload across treatment types. The report details currently approved coronary stents, providing data on current and forecast impact on the market. The report also details the current state of product development in bare stents, drug-coated or drug-eluting stents and bioabsorbable stents in coronary applications and details the products under development, the anticipated timeline and impact of their market introduction. The report assesses the current and ten-year forecast global market for coronary stents, with segmentation by U.S., Europe, Asia/Pacific and Rest of World. The report provides competitor market shares by these geographic regions. The leading and key emerging coronary stent manufacturers are profiled with current product offerings, development status and market strengths/advantages.
The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.
For more details on this report, including description, table of
contents, list of exhibits and ordering information, see http://www.mediligence.com/rpt/rpt-c245.htm.
Tags:
stents, drug eluting,
drug-coated,
angioplasty,
PTCA
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on
medical technology to the medical products and investment industries.
The company publishes dedicated
Reports on medical technology
markets and offers the
Medtech Startups Database on hundreds
of newly founded medtech companies.